Close the sale of the healthcare provider software business to Dedalus Group
Delivered after the deadline (1 days after the deadline)
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 20 Jul 2020
- Due
- 31 Mar 2021
- Delivered
- 1 Apr 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The transaction was approved by DXC’s Board of Directors and is expected to close by March 2021, subject to the satisfaction of customary closing conditions”
What we found
Evidence strength A What the grades mean
DXC Technology announced the sale of its healthcare provider software business was expected to close by March 2021, but the transaction actually closed on April 1, 2021.
-
A DXC Technology 10-K filed 2021-05-28
“The transaction closed on April 1, 2021.” ✓ confirmed on the page
Market reaction: the shares moved +3.3% against the S&P 500 over the three sessions around the disclosure (27 May 2021 to 2 Jun 2021). What this measures
Checked 21 Oct 2026.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- 2 versions
-
Version 1 · original · stated 20 Jul 2020
Deadline 31 Mar 2021 (“by March 2021”) · wording expected
-
Version 2 · stated 5 Nov 2020
Deadline 31 Mar 2021 (“by the end of this fiscal year”) · wording firm
“We are also on track to close the sale of our Healthcare Provider Software business to Dedalus by the end of this fiscal year.”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- sale of healthcare provider software business
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: subject to the satisfaction of customary closing conditions; receipt of certain third-party consents; regulatory approvals
- Depends on
- Regulatory, Partner
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you DXC Technology? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-DXC-018842 · Corrections policy